Florida’s medical marijuana market generated $165,177,271 in sales in February, surpassing the $160 million recorded in January and marking the highest monthly total since March 2024.
According to data released today by the research firm Headset, February sales saw dried marijuana flower leading the market with 44% of total sales, followed by vapor pens (21%), edibles (14%), concentrates (11%), pre-rolls (5%), capsules (2%), and tinctures and topicals (a combined 3%).
The $165 million in February sales marks a roughly 7% increase from the $153.8 million sold in February 2024.
Florida remains the largest medical marijuana market in the U.S., with 900,540 registered patients as of the end of January, according to the Florida Department of Health. The state’s medical marijuana program, established through the passage of Amendment 2 in 2016, allows patients with qualifying conditions—including chronic pain, cancer, epilepsy, and PTSD—to purchase marijuana from a licensed dispensary, so long as they have a recommendation from a physician.
February’s $165 million in sales in the third highest month of all time for Florida’s medical marijuana market, surpassed only by March 2024 ($172 million) and December 2023 ($168.8 million).
According to polling released last month, 67% of voters in the state support legalizing recreational marijuana, allowing it to be sold through licensed retail outlets. An initiative to do just that was recently filed by Smart & Safe Florida, with the group aiming for the November 2026 ballot.
